The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as AR...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2019, Vol.2019 (2019), p.1-16 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 16 |
|---|---|
| container_issue | 2019 |
| container_start_page | 1 |
| container_title | BioMed research international |
| container_volume | 2019 |
| creator | Xu, Shufeng Fu, Zhanzhao Han, A’meng Zhang, Yanqiu Zhang, Zijian |
| description | Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics. |
| doi_str_mv | 10.1155/2019/8989241 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6442440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A619216098</galeid><sourcerecordid>A619216098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4141-4225f4d4d787e360322ae78d9a64170916e0e346671637cca819a86a050b0ff63</originalsourceid><addsrcrecordid>eNqNkkFv0zAUxyMEYtPYjTOyxAVpDfOzHce5IFVhQKUypq6cLS9xWk-JndnJ0L7IPi8OLR1wwgfbf_v3_s9PfknyGvB7gCw7JxiKc1GIgjB4lhwTCizlwOD5YU_pUXIawi2OQwDHBX-ZHFHAMVzQ4-RxvdXoowum04M3FSpd1ytvgrMBuQaVq_UMLb5O83xVziZ9tpPK1r9UPJ7AKxcG12uvBnOv0UrVxg3bKPsHZCxaLBbz9JKg60FtNLp0Nr3uVNumpW5btBztBpXKVtqjqxiv7RBeJS8a1QZ9ul9Pku-fLtbll3T57fOinC_TisUqU0ZI1rCa1bnINeWYEqJ0LupCcQY5LoBrrCnjPAdO86pSAgoluMIZvsFNw-lJ8mHn2483na6rmNurVvbedMo_SKeM_PvGmq3cuHvJGSOM4Wjwbm_g3d2owyA7E6pYlrLajUESAhSyPIM8om__QW_d6G0sL1KYCZoJwE_URrVaGtu4mLeaTOWcQ0GmLxSRmu2oyrsQvG4OTwYsp86QU2fIfWdE_M2fZR7g330QgbMdsDW2Vj_Mf9rpyOhGPdFABKGE_gQN-sRZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2204835810</pqid></control><display><type>article</type><title>The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Xu, Shufeng ; Fu, Zhanzhao ; Han, A’meng ; Zhang, Yanqiu ; Zhang, Zijian</creator><contributor>Siafakas, Nikolaos ; Nikolaos Siafakas</contributor><creatorcontrib>Xu, Shufeng ; Fu, Zhanzhao ; Han, A’meng ; Zhang, Yanqiu ; Zhang, Zijian ; Siafakas, Nikolaos ; Nikolaos Siafakas</creatorcontrib><description>Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2019/8989241</identifier><identifier>PMID: 31011583</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Aged ; Analysis ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; Care and treatment ; Comparative studies ; Computed tomography ; Dosimeters ; Dosimetry ; Female ; Histograms ; Humans ; Lung cancer ; Lung cancer, Non-small cell ; Lung Neoplasms - radiotherapy ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Non-small cell lung carcinoma ; Organs ; Organs at Risk - radiation effects ; Patients ; Radiation ; Radiation therapy ; Radiometry - methods ; Radiotherapy ; Radiotherapy - adverse effects ; Radiotherapy - methods ; Radiotherapy Dosage</subject><ispartof>BioMed research international, 2019, Vol.2019 (2019), p.1-16</ispartof><rights>Copyright © 2019 Yanqiu Zhang et al.</rights><rights>COPYRIGHT 2019 John Wiley & Sons, Inc.</rights><rights>Copyright © 2019 Yanqiu Zhang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2019 Yanqiu Zhang et al. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4141-4225f4d4d787e360322ae78d9a64170916e0e346671637cca819a86a050b0ff63</citedby><cites>FETCH-LOGICAL-c4141-4225f4d4d787e360322ae78d9a64170916e0e346671637cca819a86a050b0ff63</cites><orcidid>0000-0002-8444-0040</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442440/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4009,27902,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31011583$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Siafakas, Nikolaos</contributor><contributor>Nikolaos Siafakas</contributor><creatorcontrib>Xu, Shufeng</creatorcontrib><creatorcontrib>Fu, Zhanzhao</creatorcontrib><creatorcontrib>Han, A’meng</creatorcontrib><creatorcontrib>Zhang, Yanqiu</creatorcontrib><creatorcontrib>Zhang, Zijian</creatorcontrib><title>The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics.</description><subject>Aged</subject><subject>Analysis</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>Care and treatment</subject><subject>Comparative studies</subject><subject>Computed tomography</subject><subject>Dosimeters</subject><subject>Dosimetry</subject><subject>Female</subject><subject>Histograms</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung cancer, Non-small cell</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Non-small cell lung carcinoma</subject><subject>Organs</subject><subject>Organs at Risk - radiation effects</subject><subject>Patients</subject><subject>Radiation</subject><subject>Radiation therapy</subject><subject>Radiometry - methods</subject><subject>Radiotherapy</subject><subject>Radiotherapy - adverse effects</subject><subject>Radiotherapy - methods</subject><subject>Radiotherapy Dosage</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkkFv0zAUxyMEYtPYjTOyxAVpDfOzHce5IFVhQKUypq6cLS9xWk-JndnJ0L7IPi8OLR1wwgfbf_v3_s9PfknyGvB7gCw7JxiKc1GIgjB4lhwTCizlwOD5YU_pUXIawi2OQwDHBX-ZHFHAMVzQ4-RxvdXoowum04M3FSpd1ytvgrMBuQaVq_UMLb5O83xVziZ9tpPK1r9UPJ7AKxcG12uvBnOv0UrVxg3bKPsHZCxaLBbz9JKg60FtNLp0Nr3uVNumpW5btBztBpXKVtqjqxiv7RBeJS8a1QZ9ul9Pku-fLtbll3T57fOinC_TisUqU0ZI1rCa1bnINeWYEqJ0LupCcQY5LoBrrCnjPAdO86pSAgoluMIZvsFNw-lJ8mHn2483na6rmNurVvbedMo_SKeM_PvGmq3cuHvJGSOM4Wjwbm_g3d2owyA7E6pYlrLajUESAhSyPIM8om__QW_d6G0sL1KYCZoJwE_URrVaGtu4mLeaTOWcQ0GmLxSRmu2oyrsQvG4OTwYsp86QU2fIfWdE_M2fZR7g330QgbMdsDW2Vj_Mf9rpyOhGPdFABKGE_gQN-sRZ</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Xu, Shufeng</creator><creator>Fu, Zhanzhao</creator><creator>Han, A’meng</creator><creator>Zhang, Yanqiu</creator><creator>Zhang, Zijian</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8444-0040</orcidid></search><sort><creationdate>2019</creationdate><title>The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients</title><author>Xu, Shufeng ; Fu, Zhanzhao ; Han, A’meng ; Zhang, Yanqiu ; Zhang, Zijian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4141-4225f4d4d787e360322ae78d9a64170916e0e346671637cca819a86a050b0ff63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Analysis</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>Care and treatment</topic><topic>Comparative studies</topic><topic>Computed tomography</topic><topic>Dosimeters</topic><topic>Dosimetry</topic><topic>Female</topic><topic>Histograms</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung cancer, Non-small cell</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Non-small cell lung carcinoma</topic><topic>Organs</topic><topic>Organs at Risk - radiation effects</topic><topic>Patients</topic><topic>Radiation</topic><topic>Radiation therapy</topic><topic>Radiometry - methods</topic><topic>Radiotherapy</topic><topic>Radiotherapy - adverse effects</topic><topic>Radiotherapy - methods</topic><topic>Radiotherapy Dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Shufeng</creatorcontrib><creatorcontrib>Fu, Zhanzhao</creatorcontrib><creatorcontrib>Han, A’meng</creatorcontrib><creatorcontrib>Zhang, Yanqiu</creatorcontrib><creatorcontrib>Zhang, Zijian</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Shufeng</au><au>Fu, Zhanzhao</au><au>Han, A’meng</au><au>Zhang, Yanqiu</au><au>Zhang, Zijian</au><au>Siafakas, Nikolaos</au><au>Nikolaos Siafakas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2019</date><risdate>2019</risdate><volume>2019</volume><issue>2019</issue><spage>1</spage><epage>16</epage><pages>1-16</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Currently, studies about PORT in stage IIIA-N2 NSCLC patients in recent years have mostly adopted the conformal radiation therapy (CRT) technique, while other modern techniques such as intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT, hereinafter referred to as ARC), helical tomotherapy (HT), and so forth are also developing quickly. In this paper, we intended to compare the dosimetric characteristics of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of PORT in stage IIIA-N2 NSCLC patients. Ten patients with stage IIIA-N2 completely resected NSCLC, whom were treated by PORT in the radiotherapy department of our hospital from January 1, 2017, to January 1, 2018, were randomly selected in this study. For each patient, the CRT plan, IMRT plan, ARC plan, CRT+IMRT plan, and CRT+ARC plan were designed separately on the same set of CT images. The isodose distribution and dose-volume histogram (DVH) of the five plans were compared to determine the dosimetric parameters of the targets, OAR (organs at risk), and the normal tissue (defined as body subtracted to PTV (planning target volume), B-P). No plan had absolute dosimetry advantages than any other plans. In clinical practice, the plans could be chosen according to their dosimetry characteristics.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>31011583</pmid><doi>10.1155/2019/8989241</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-8444-0040</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2019, Vol.2019 (2019), p.1-16 |
| issn | 2314-6133 2314-6141 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6442440 |
| source | MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; PubMed Central; Alma/SFX Local Collection |
| subjects | Aged Analysis Carcinoma, Non-Small-Cell Lung - radiotherapy Care and treatment Comparative studies Computed tomography Dosimeters Dosimetry Female Histograms Humans Lung cancer Lung cancer, Non-small cell Lung Neoplasms - radiotherapy Male Medical research Medicine, Experimental Middle Aged Non-small cell lung carcinoma Organs Organs at Risk - radiation effects Patients Radiation Radiation therapy Radiometry - methods Radiotherapy Radiotherapy - adverse effects Radiotherapy - methods Radiotherapy Dosage |
| title | The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T18%3A32%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Dosimetric%20Comparisons%20of%20CRT,%20IMRT,%20ARC,%20CRT+IMRT,%20and%20CRT+ARC%20of%20Postoperative%20Radiotherapy%20in%20IIIA-N2%20Stage%20Non-Small-Cell%20Lung%20Cancer%20Patients&rft.jtitle=BioMed%20research%20international&rft.au=Xu,%20Shufeng&rft.date=2019&rft.volume=2019&rft.issue=2019&rft.spage=1&rft.epage=16&rft.pages=1-16&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2019/8989241&rft_dat=%3Cgale_pubme%3EA619216098%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2204835810&rft_id=info:pmid/31011583&rft_galeid=A619216098&rfr_iscdi=true |